Skip to main content
PMC home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1997 Dec;41(12):2634–2639. doi: 10.1128/aac.41.12.2634

Antimicrobial susceptibility testing of 230 Helicobacter pylori strains: importance of medium, inoculum, and incubation time.

S H Hartzen 1, L P Andersen 1, A Bremmelgaard 1, H Colding 1, M Arpi 1, J Kristiansen 1, T Justesen 1, F Espersen 1, N Frimodt-Møller 1, O Bonnevie 1
PMCID: PMC164182  PMID: 9420032

Abstract

No standardized method of susceptibility testing for Helicobacter pylori is currently available, so before a large agar dilution study comprising 230 H. pylori strains belonging to more than 80 genetically different groups was initiated, we performed a relatively small preliminary study to determine the influences of medium, inoculum density, and incubation time. Seven media were investigated and were primarily evaluated on the basis of their abilities to support growth both semiquantitatively and qualitatively; Iso-Sensitest agar supplemented with 10% horse blood was found to be well suited for the purpose; this was closely followed by Mueller-Hinton agar with 10% horse blood, Mueller-Hinton with 10% sheep blood, and finally, 7% lysed horse blood agar. Investigations of two inoculum densities and two incubation times resulted in recommendations for the use of 10(9) CFU/ml (10[6] CFU/spot) as the inoculum and 72 h as the incubation time. A modest inoculum effect was noted for amoxicillin and metronidazole. By the methodology derived from our preliminary study, the susceptibilities of 230 H. pylori strains to six antibiotics were subsequently determined. The results were generally in accord with those of others, and apart from metronidazole, the MIC of which for approximately 25% of the strains tested was >8 microg/ml, resistance was low in Denmark. The situation might, however, quickly change when and if the number of indications for antibiotic therapy for H. pylori infections increase. Consequently, susceptibility testing of all H. pylori strains is recommended in order to survey the development of resistance, and in our hands the described methodology was relatively easy to perform and the results were easy to read.

Full Text

The Full Text of this article is available as a PDF (138.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andreasen J. J., Andersen L. P. In vitro susceptibility of Campylobacter pyloridis to cimetidine, sucralfate, bismuth and sixteen antibiotics. Acta Pathol Microbiol Immunol Scand B. 1987 Apr;95(2):147–149. doi: 10.1111/j.1699-0463.1987.tb03103.x. [DOI] [PubMed] [Google Scholar]
  2. Banatvala N., Davies G. R., Abdi Y., Clements L., Rampton D. S., Hardie J. M., Feldman R. A. High prevalence of Helicobacter pylori metronidazole resistance in migrants to east London: relation with previous nitroimidazole exposure and gastroduodenal disease. Gut. 1994 Nov;35(11):1562–1566. doi: 10.1136/gut.35.11.1562. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Coudron P. E., Stratton C. W. Factors affecting growth and susceptibility testing of Helicobacter pylori in liquid media. J Clin Microbiol. 1995 Apr;33(4):1028–1030. doi: 10.1128/jcm.33.4.1028-1030.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Czinn S. J., Carr H., Hupertz V. Susceptibility of Campylobacter pylori to the newer cephalosporin antibiotics. Chemotherapy. 1989;35(3):164–167. doi: 10.1159/000238665. [DOI] [PubMed] [Google Scholar]
  5. Czinn S., Carr H., Aronoff S. Susceptibility of Campylobacter pyloridis to three macrolide antibiotics (erythromycin, roxithromycin [RU 28965], and CP 62,993) and rifampin. Antimicrob Agents Chemother. 1986 Aug;30(2):328–329. doi: 10.1128/aac.30.2.328. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. DeCross A. J., Marshall B. J., McCallum R. W., Hoffman S. R., Barrett L. J., Guerrant R. L. Metronidazole susceptibility testing for Helicobacter pylori: comparison of disk, broth, and agar dilution methods and their clinical relevance. J Clin Microbiol. 1993 Aug;31(8):1971–1974. doi: 10.1128/jcm.31.8.1971-1974.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. García-Rodríguez J. A., García Sánchez J. E., García García M. I., García Sánchez E., Muñoz Bellido J. L. In vitro activities of new oral beta-lactams and macrolides against Campylobacter pylori. Antimicrob Agents Chemother. 1989 Sep;33(9):1650–1651. doi: 10.1128/aac.33.9.1650. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Glupczynski Y., Delmee M., Bruck C., Labbe M., Avesani V., Burette A. Susceptibility of clinical isolates of Campylobacter pylori to 24 antimicrobial and anti-ulcer agents. Eur J Epidemiol. 1988 Jun;4(2):154–157. doi: 10.1007/BF00144743. [DOI] [PubMed] [Google Scholar]
  9. Goddard A. F., Logan R. P. Antimicrobial resistance and Helicobacter pylori. J Antimicrob Chemother. 1996 Apr;37(4):639–643. doi: 10.1093/jac/37.4.639. [DOI] [PubMed] [Google Scholar]
  10. Hardy D. J., Hanson C. W., Hensey D. M., Beyer J. M., Fernandes P. B. Susceptibility of Campylobacter pylori to macrolides and fluoroquinolones. J Antimicrob Chemother. 1988 Nov;22(5):631–636. doi: 10.1093/jac/22.5.631. [DOI] [PubMed] [Google Scholar]
  11. Lambert T., Mégraud F., Gerbaud G., Courvalin P. Susceptibility of Campylobacter pyloridis to 20 antimicrobial agents. Antimicrob Agents Chemother. 1986 Sep;30(3):510–511. doi: 10.1128/aac.30.3.510. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. McNulty C. A., Dent J. C. Susceptibility of clinical isolates of Campylobacter pylori to twenty-one antimicrobial agents. Eur J Clin Microbiol Infect Dis. 1988 Aug;7(4):566–569. doi: 10.1007/BF01962617. [DOI] [PubMed] [Google Scholar]
  13. McNulty C. A., Dent J., Wise R. Susceptibility of clinical isolates of Campylobacter pyloridis to 11 antimicrobial agents. Antimicrob Agents Chemother. 1985 Dec;28(6):837–838. doi: 10.1128/aac.28.6.837. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Mera S. L. Peptic ulcers and gastric cancer. Br J Biomed Sci. 1995 Dec;52(4):271–281. [PubMed] [Google Scholar]
  16. Reyn A., Bentzon M. W. Comparison of a selective and a non-selective medium in the diagnosis of gonorrhoea to ascertain the sensitivity of Neisseria gonorrhoeae to vancomycin. Br J Vener Dis. 1972 Oct;48(5):363–368. doi: 10.1136/sti.48.5.363. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Simor A. E., Ferro S., Low D. E. Comparative in vitro activities of six new fluoroquinolones and other oral antimicrobial agents against Campylobacter pylori. Antimicrob Agents Chemother. 1989 Jan;33(1):108–109. doi: 10.1128/aac.33.1.108. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Xia H. X., Buckley M., Keane C. T., O'Morain C. A. Clarithromycin resistance in Helicobacter pylori: prevalence in untreated dyspeptic patients and stability in vitro. J Antimicrob Chemother. 1996 Mar;37(3):473–481. doi: 10.1093/jac/37.3.473. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES